Satellos Bioscience Inc. (TSX:MSCL)
Canada flag Canada · Delayed Price · Currency is CAD
15.77
+0.62 (4.09%)
Feb 11, 2026, 3:59 PM EST

Satellos Bioscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
19.340.0716.711.423.850.56
Short-Term Investments
15.318.4813.27---
Cash & Short-Term Investments
34.6148.5529.981.423.850.56
Cash Growth
99.65%61.96%2008.62%-63.07%583.57%83.00%
Other Receivables
0.210.440.440.190.420.32
Receivables
0.210.440.440.190.420.32
Prepaid Expenses
0.41.760.110.030.030
Other Current Assets
2.28-00--
Total Current Assets
37.550.7430.531.654.30.89
Property, Plant & Equipment
0.0100.010.010.010
Long-Term Investments
--0.030.03--
Other Intangible Assets
--2.972.895.64-
Total Assets
37.550.7533.544.589.950.89
Accounts Payable
1.392.060.791.080.890.1
Accrued Expenses
21.521.961.010.770.07
Total Current Liabilities
3.53.582.742.091.660.17
Long-Term Debt
-----0.86
Total Liabilities
3.53.582.742.091.661.03
Common Stock
85.5573.4846.8822.3222.383.42
Additional Paid-In Capital
9.327.186.442.720.980.19
Retained Earnings
-74.67-52.54-35.97-23.36-16.03-3.76
Comprehensive Income & Other
13.8119.0513.450.80.97-
Shareholders' Equity
3447.1630.82.498.28-0.14
Total Liabilities & Equity
37.550.7533.544.589.950.89
Total Debt
-----0.86
Net Cash (Debt)
34.6148.5529.981.423.85-0.29
Net Cash Growth
99.65%61.96%2008.62%-63.07%--
Net Cash Per Share
2.615.084.160.481.92-0.20
Filing Date Shares Outstanding
15.4613.829.43.482.7512.09
Total Common Shares Outstanding
15.4213.829.43.482.7512.09
Working Capital
33.9947.1627.79-0.442.640.71
Book Value Per Share
2.203.413.280.713.01-0.01
Tangible Book Value
3447.1627.83-0.42.64-0.14
Tangible Book Value Per Share
2.203.412.96-0.120.96-0.01
Machinery
---0.010.01-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.